Crossmark Global Holdings’s Haemonetics HAE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $207K | Buy |
+2,762
| New | +$177K | ﹤0.01% | 1225 |
|
|
2026
Q1 | – | Sell |
-2,724
| Closed | -$218K | – | 1259 |
|
|
2025
Q4 | $218K | Buy |
+2,724
| New | +$183K | ﹤0.01% | 1156 |
|
|
2025
Q3 | – | Sell |
-3,580
| Closed | -$267K | – | 1310 |
|
|
2025
Q2 | $267K | Sell |
3,580
-2,274
| -39% | -$151K | ﹤0.01% | 1152 |
|
|
2025
Q1 | $372K | Sell |
5,854
-30
| -0.5% | -$2.04K | 0.01% | 987 |
|
|
2024
Q4 | $459K | Sell |
5,884
-630
| -10% | -$50.6K | 0.01% | 867 |
|
|
2024
Q3 | $524K | Sell |
6,514
-3,484
| -35% | -$281K | 0.01% | 844 |
|
|
2024
Q2 | $827K | Buy |
9,998
+2,370
| +31% | +$208K | 0.02% | 646 |
|
|
2024
Q1 | $651K | Buy |
7,628
+4,002
| +110% | +$314K | 0.01% | 756 |
|
|
2023
Q4 | $310K | Sell |
3,626
-393
| -10% | -$34K | 0.01% | 1056 |
|
|
2023
Q3 | $372K | Sell |
4,019
-41
| -1% | -$3.66K | 0.01% | 922 |
|
|
2023
Q2 | $377K | Sell |
4,060
-276
| -6% | -$23.3K | 0.01% | 960 |
|
|
2023
Q1 | $358K | Buy |
4,336
+148
| +4% | +$12K | 0.01% | 970 |
|
|
2022
Q4 | $330K | Buy |
4,188
+83
| +2% | +$6.67K | 0.01% | 980 |
|
|
2022
Q3 | $304K | Sell |
4,105
-305
| -7% | -$21.9K | 0.01% | 986 |
|
|
2022
Q2 | $287K | Sell |
4,410
-10
| -0.2% | -$592 | 0.01% | 1048 |
|
|
2022
Q1 | $279K | Buy |
4,420
+10
| +0.2% | +$544 | 0.01% | 1173 |
|
|
2021
Q4 | $234K | Buy |
4,410
+510
| +13% | +$31.1K | 0.01% | 1276 |
|
|
2021
Q3 | $275K | Sell |
3,900
-20
| -0.5% | -$1.26K | 0.01% | 1206 |
|
|
2021
Q2 | $261K | Sell |
3,920
-450
| -10% | -$31.8K | 0.01% | 1253 |
|
|
2021
Q1 | $485K | Sell |
4,370
-20
| -0.5% | -$2.48K | 0.01% | 917 |
|
|
2020
Q4 | $521K | Sell |
4,390
-130
| -3% | -$14K | 0.01% | 830 |
|
|
2020
Q3 | $394K | Sell |
4,520
-130
| -3% | -$11.4K | 0.01% | 880 |
|
|
2020
Q2 | $416K | Buy |
4,650
+470
| +11% | +$47.5K | 0.01% | 837 |
|
|
2020
Q1 | $417K | Sell |
4,180
-70
| -2% | -$7.59K | 0.01% | 710 |
|
|
2019
Q4 | $488K | Sell |
4,250
-780
| -16% | -$94.4K | 0.01% | 810 |
|
|
2019
Q3 | $634K | Sell |
5,030
-250
| -5% | -$31.7K | 0.02% | 695 |
|
|
2019
Q2 | $635K | Sell |
5,280
-359
| -6% | -$35.3K | 0.02% | 702 |
|
|
2019
Q1 | $493K | Buy |
5,639
+90
| +2% | +$8.19K | 0.01% | 816 |
|
|
2018
Q4 | $555K | Buy |
5,549
+930
| +20% | +$97.7K | 0.02% | 728 |
|
|
2018
Q3 | $529K | Sell |
4,619
-60
| -1% | -$6.21K | 0.01% | 919 |
|
|
2018
Q2 | $420K | Sell |
4,679
-3,450
| -42% | -$291K | 0.01% | 1075 |
|
|
2018
Q1 | $595K | Sell |
8,129
-1,949
| -19% | -$134K | 0.02% | 818 |
|
|
2017
Q4 | $585K | Buy |
10,078
+229
| +2% | +$12.1K | 0.01% | 879 |
|
|
2017
Q3 | $442K | Buy |
+9,849
| New | +$409K | 0.01% | 1037 |
|
|
2016
Q3 | $442K | Buy |
+9,849
| New | +$338K | 0.01% | 1037 |
|
Other funds holding HAE
AI
Crossmark Global Holdings's HAE Position: Q2 2026 in Review
Crossmark Global Holdings opened a new position in Haemonetics (HAE) in Q2 2026: 2,762 shares worth $207K. The stake represents ﹤0.01% of the portfolio and ranks #1225 among its holdings. This is a return to the name: Crossmark Global Holdings previously reported a position in HAE as recently as Q4 2025.
Crossmark Global Holdings first reported a position in HAE in Q3 2016 and has held it in 35 quarters since. The position peaked at $827K in Q2 2024. 329 funds tracked by Wall St. Rank hold HAE as of Q2 2026.
- Crossmark Global Holdings held 2,762 shares of Haemonetics worth $207K as of Q2 2026.
- Haemonetics was a new Crossmark Global Holdings position in Q2 2026.
- Haemonetics made up ﹤0.01% of Crossmark Global Holdings's portfolio in Q2 2026, its #1225 holding.
- Crossmark Global Holdings first reported a position in Haemonetics in Q3 2016 and has held it in 35 quarters since.
- Crossmark Global Holdings's Haemonetics position peaked at $827K in Q2 2024.
- 329 funds tracked by Wall St. Rank held Haemonetics as of Q2 2026.
Based on Crossmark Global Holdings's 13F filing for Q2 2026, filed 16 Jul 2026.